Atul Bioscience received EIR from USFDA for Ambernath facility
The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations
The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Shivani Satish Wagh takes on the role of Joint Managing Director
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Ibara will drive AI-powered clinical research innovation
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Jubilant's Radiopharma Business to expand positron emission tomography radiopharmacy network
Accelerating sustainability in Indian pharma industry
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Subscribe To Our Newsletter & Stay Updated